Leadership Transition With the recent departure of CEO Kári Stefánsson, deCODE Genetics may be seeking strategic leadership and new direction opportunities, presenting an entry point for collaborations that align with emerging corporate goals.
Acquisition & Growth Following its acquisition by Eruptr LLC in April 2023, deCODE Genetics is likely to expand its product offerings and market reach, creating opportunities for sales of integrated genomic and health risk assessment solutions.
Industry Collaborations Active partnerships with healthcare organizations and bioscience firms, such as Intermountain Healthcare and SomaLogic, highlight potential for providing innovative genetic research tools and services to healthcare providers and biotech partners.
Technology & Innovation deCODE's use of advanced tech stacks and involvement in large-scale DNA mapping projects suggest a demand for cutting-edge genomic analysis platforms, opening avenues for sales of high-performance data processing and analytical software.
Market Position Operating in a competitive landscape with companies like 23andMe and Ancestry, deCODE's focus on genetic research and disease prevention positions it to leverage emerging market trends in personalized medicine and population health, offering opportunities for tailored solutions.
$250M$500M
$500M$1B
$250M$500M
$100M$250M
$1M$10M
$1M$10M
$25M$50M
$10M$25M
$1M$10MdeCODE Genetics Inc. uses 8 technology products and services including W3 Total Cache, WordPress, Priority Hints, and more. Explore deCODE Genetics Inc.'s tech stack below.
| deCODE Genetics Inc. Email Formats | Percentage |
| First.Last@decode.com | 76% |
| FLast@decode.com | 11% |
| FirstL@decode.com | 9% |
| First@decode.com | 4% |
Biotechnology ResearchCapital Region, Iceland201-500 Employees
deCODE genetics is a global leader in analysing and understanding the human genome. Using its unique expertise and population resources, deCODE has discovered genetic risk factors for dozens of common diseases. The purpose of understanding the genetics of disease is to use that information to create new means of diagnosing, treating and preventing disease
Company Overview
Media & News
Funding & FinancialsdeCODE Genetics Inc.'s revenue is estimated to be in the range of $1B$10B
Funding & FinancialsdeCODE Genetics Inc.'s revenue is estimated to be in the range of $1B$10B
1-888-653-2347 
support@leadiq.com